Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥740.3bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.84T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥215.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥201.3bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥621.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥157.3bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥482.3bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥157.8bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥485.3bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥7.16Tat 2024-03-31Cons.Assets IFRS
Total assets¥7.28Tat 2023-12-31Cons.Assets IFRS
Total assets¥6.35Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.09Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥3.37Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥4.07Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥3.91Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥3.99Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.83Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥766.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.04Tat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥567.0bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥27.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥126.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥341.2bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥270.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥88.582024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥271.692023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥88.572024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥271.632023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio52.6%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥322m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥705m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥11.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥9.3bn
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥774m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31¥24m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥23.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥3.8bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2024-01-01 → 2024-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥6m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2024-01-01 → 2024-03-31¥2.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2024-01-01 → 2024-03-31¥681.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥64m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥231.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2024-01-01 → 2024-03-31¥219.2bn
—segment totalrevenue2024-01-01 → 2024-03-31¥740.1bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥740.0bn
—segment totalrevenue intersegment2024-01-01 → 2024-03-31¥69m
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥237.7bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥225.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 891
ItemContextValueUnit
Other non current assets nca IFRSCurrentQuarterInstant6928000000JPY
Deferred tax assets IFRSPrior1YearInstant89379000000JPY
Deferred tax assets IFRSCurrentQuarterInstant95954000000JPY
Non current assets IFRSPrior1YearInstant4022536000000JPY
Non current assets IFRSCurrentQuarterInstant4174191000000JPY
Assets IFRSPrior1YearInstant7282097000000JPY
Assets IFRSCurrentQuarterInstant7159003000000JPY
Trade and other payables cl IFRSPrior1YearInstant592802000000JPY
Trade and other payables cl IFRSCurrentQuarterInstant523215000000JPY
Bonds and borrowings cl IFRSPrior1YearInstant233333000000JPY
Bonds and borrowings cl IFRSCurrentQuarterInstant80321000000JPY
Income taxes payable cl IFRSPrior1YearInstant29647000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant37456000000JPY
Other financial liabilities cl IFRSPrior1YearInstant44470000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant44996000000JPY
Provisions cl IFRSPrior1YearInstant18634000000JPY
Provisions cl IFRSCurrentQuarterInstant17384000000JPY
Other current liabilities cl IFRSPrior1YearInstant1008390000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant926436000000JPY
Total current liabilities IFRSPrior1YearInstant1927276000000JPY
Total current liabilities IFRSCurrentQuarterInstant1629808000000JPY
Bonds and borrowings ncl IFRSPrior1YearInstant908926000000JPY
Bonds and borrowings ncl IFRSCurrentQuarterInstant939268000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant40678000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant39282000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant279443000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant279153000000JPY
Provisions ncl IFRSPrior1YearInstant45527000000JPY
Provisions ncl IFRSCurrentQuarterInstant45790000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant127170000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant113845000000JPY
Deferred tax liabilities IFRSPrior1YearInstant40586000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant39388000000JPY
Non current labilities IFRSPrior1YearInstant1442329000000JPY
Non current labilities IFRSCurrentQuarterInstant1456725000000JPY
Liabilities IFRSPrior1YearInstant3369605000000JPY
Liabilities IFRSCurrentQuarterInstant3086533000000JPY
Share capital IFRSPrior1YearInstant100000000000JPY
Share capital IFRSCurrentQuarterInstant100000000000JPY
Capital surplus IFRSPrior1YearInstant736478000000JPY
Capital surplus IFRSCurrentQuarterInstant736444000000JPY
Treasury shares IFRSPrior1YearInstant-489194000000JPY
Treasury shares IFRSCurrentQuarterInstant-489122000000JPY
Other components of equity IFRSPrior1YearInstant290550000000JPY
Other components of equity IFRSCurrentQuarterInstant470118000000JPY
Retained earnings IFRSPrior1YearInstant3192323000000JPY
Retained earnings IFRSCurrentQuarterInstant3172063000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant3830156000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant3989504000000JPY
Non controlling interests IFRSPrior1YearInstant82336000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass